Primecap Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $71.9M | Sell |
|
|||||
|
2025
Q2 | $65.9M | Buy |
|
|||||
|
2025
Q1 | $42.3M | Sell |
|
|||||
|
2024
Q4 | $53.7M | Sell |
|
|||||
|
2024
Q3 | $46.5M | Sell |
|
|||||
|
2024
Q2 | $56.3M | Buy |
|
|||||
|
2024
Q1 | $55.1M | Buy |
|
|||||
|
2023
Q4 | $52.5M | Buy |
|
|||||
|
2023
Q3 | $44.1M | Sell |
|
|||||
|
2023
Q2 | $37.1M | Buy |
|
|||||
|
2023
Q1 | $37.6M | Buy |
|
|||||
|
2022
Q4 | $609K | Buy |
|